General Meeting

Investors Menu

The General Meeting is the company’s supreme decision-making body and according to the Articles of Association is to be held within six months of the end of the fiscal year. Shareholders who are registered in the share register five days before the meeting and who sign up correctly are entitled to participate. Notification shall be made to the company by the date specified in the summons for the meeting. All shareholders registered in the share register on the record date and who have notified their participation in time are entitled to attend the meeting and vote for the total holding of shares.

The summons to attend the General Meeting shall be given by advertisement via mail and in Swedish domestic newspapers and by making the summons available on the company website. The fact that the summons has been issued shall simultaneously be published in Dagens Industri and on the company’s website.

At the AGM, the shareholders elect the Board of Directors and if applicable, auditors. The meeting also decides on, among other things, how the Nomination Committee shall be appointed, discharge of liability for the Board and the Chief Executive Officer, adoption of the Annual Report, appropriation of profits, fees for the Board and the auditors as well as guidelines for compensation to the Chief Executive Officer and other senior executives.

The summons, communiqués and other materials for the meetings are published on the company’s website.

The Annual General Meeting of Episurf Medical was held on 25 May 2026 in Stockholm, Sweden.

AGM 2026
 
EGM APRIL 2026
EGM 2026
EGM 2025
Episurf Medical’s Extra General Meeting was held on Monday, August 4, 2025 at 14:00 (CEST) at the offices of Snellman Attorneys AB at Kungsträdgårdsgatan 20 in Stockholm, Sweden.  
AGM 2025
Episurf Medicals AGM was held on Thursday, April 10, 2025 at 16:30 at Karlavägen 60, 114 49 Stockholm.
EGM 2024
Episurf Medical’s Extra General Meeting was held on Wednesday, May 22, 2024 at 09:00 at Karlavägen 60, 114 49 Stockholm
Documents:
AGM 2024
Episurf Medical’s Annual General Meeting was held on Tuesday, April 9, 2024 at 15:00 at Karlavägen 60, 114 49 Stockholm
Documents:
AGM 2023
Episurf Medical’s Annual General Meeting was held on Thursday, May 4, 2023 at 16:30 at Karlavägen 60, 114 49 Stockholm
Documents:
AGM 2022
Episurf Medical’s Annual General Meeting was held on Monday, April 4, 2022. Due to the Covid-19 pandemic and introduced restrictions, the Meeting was conducted without the physical presence of shareholders, proxies, or third parties. Shareholders had the opportunity to exercise their voting rights by post before the Meeting in accordance with Sections 20 and 22 of the Swedish Act on Temporary Exemptions to Facilitate the Execution of General Meetings in Companies and Associations. Documents:
AGM 2021
Episurf Medical’s Annual General Meeting was held on Monday, May 10, 2021. Due to the Covid-19 pandemic and introduced restrictions, the Meeting was conducted without the physical presence of shareholders, proxies, or third parties. Shareholders had the opportunity to exercise their voting rights by post before the Meeting in accordance with Sections 20 and 22 of the Swedish Act on Temporary Exemptions to Facilitate the Execution of General Meetings in Companies and Associations.
AGM 2020
Episurf Medical’s Annual General Meeting was held on Thursday, April 2, 2020 at 17:30 at Karlavägen 60, 114 49 Stockholm Documents:
Extra general meeting 2020
The English text in this notice is a translation of the Swedish original. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Notice of Extraordinary General Meeting of Episurf Medical AB (publ) The shareholders in Episurf Medical AB (publ), 556767-0541 (“Episurf” or the “Company”), are hereby summoned to an Extraordinary General Meeting (the “Meeting”) on Tuesday 10 March 2020 at 12 p.m. (CET) at the premises of the Company, Karlavägen 60, 114 49 in Stockholm. Notice of attendance Shareholders who wish to attend and vote at the Meeting must be registered in the share register maintained by Euroclear Sweden AB on Wednesday 4 March 2020, and give notice of attendance to the Company by mail to Episurf Medical AB (publ), Karlavägen 60, 114 49 Stockholm, by the form below or by email to ir@episurf.se. Notice of attendance must be received by the Company no later than on Thursday 5 March 2020. The notification shall include the shareholder’s name, personal identification number/corporate registration number and daytime telephone number. The notice of attendance shall also include the number of accompanying advisors (not more than two) who are attending the Meeting. Shareholders who are represented by a proxy must submit a dated and signed power of attorney. The original of the power of attorney and, for legal entities, a certified copy of a certificate of registration, should be sent to the Company at the address above in ample time prior to the Meeting. The power of attorney may not be valid for a longer period than one year from its issuance. However, the power of attorney may be valid for up to five years from its issuance if so explicitly stated. A form of power of attorney will be available on the Company’s website, www.episurf.com. Shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own name to be entitled to participate at the Meeting. Such registration must be completed at Euroclear Sweden AB no later than on Wednesday 4 March 2020. The nominee should therefore be instructed well in advance of this date. Proposed agenda
  • Opening of the Meeting
  • Appointment of a Chairman of the Meeting
  • Preparation and approval of the voting list
  • Election of one or two persons to approve the minutes of the Meeting
  • Approval of the agenda
  • Determination of whether the Meeting has been duly convened
  • Resolution on adoption of new Articles of Association
  • Resolution on approval of a new issue of shares with preferential rights for shareholders
  • Resolution on approval of a directed new issue of shares
  • Closing of the Meeting
Proposal under item 2; Appointment of a Chairman of the Meeting The Board of Directors proposes that Emma Norburg is appointed Chairman of the Meeting. Proposal under item 7; Resolution on adoption of new Articles of Association To enable the share issues pursuant to items 8 and 9 below, the Board of Directors proposes that the Meeting resolves on the following amendments to the Articles of Association of the Company:
  • The provision in § 4 regarding the limits of the share capital of the Company is amended so that the share capital shall be no less than SEK 27,302,316.80 nor exceed SEK 109,209,267.20.
  • The provision in § 5 regarding the number of shares in the Company is amended so that the number of shares shall be no less than 90,930,755 and no more than 363,723,020.
A resolution in accordance with the proposal of the Board of Directors under this item 7 must be supported by shareholders representing at least two-thirds of the votes cast as well as the shares represented at the Meeting. Proposal under item 8; Resolution on approval of a new issue of shares with preferential rights for shareholders Subject to the Meeting’s subsequent approval, the Board of Directors in Episurf resolved, on 7 February 2020, on a new issue of class B shares with preferential rights for shareholders (the ”Rights Issue”), on the following main terms and conditions. The Company’s share capital shall be increased with no more than SEK 10,238,368.76 by a new issue of no more than 34,099,033 class B shares. The Company’s shareholders shall have preferential rights to subscribe for the new class B shares pro rata to the number of shares previously held by the holder, regardless of share class. For each share held on the record day, shareholders will receive three (3) subscription rights of class B. Eight (8) subscription rights of a share of class B entitles the holder to subscribe for one (1) new class B share. In accordance with the aforementioned, eight (8) shares previously held will entitle a subscription for three (3) new class B shares. The record day for determining which shareholders shall be entitled to subscribe for shares with preferential rights (i.e. to receive subscription rights) shall be 16 March 2020. If not all shares issued in the Rights Issue are subscribed for with subscription rights, the Board of Directors shall decide on the allotment of new class B shares subscribed for without subscription rights in accordance with the following:
  • Firstly, allotment shall be made to those who have subscribed for class B shares with subscription rights and who wishes to subscribe for additional shares, irrespective of whether or not the subscriber was a shareholder of the Company as of the record date, pro rata to their subscription with subscription rights, and to the extent this cannot be effected, by the drawing of lots.
  • Secondly, allotment shall be made to others that have announced their interest in subscription of class B shares without subscription rights (and who are not included under item a) above), pro rata to the their announced interest, and to the extent this cannot be effected, by the drawing of lots.
  • Ultimately, allotment shall be made to those who have issued guarantee commitments regarding the subscription of class B shares in relation to the terms and conditions of the respective guarantee commitment.
Subscription of new shares with subscription rights shall be made by payment in cash during the period from and including 19 March 2020 up to and including 2 April 2020. Subscription of shares without subscription rights shall take place during the same period. Subscription shall in such case be made on a separate subscription list. Payment for shares subscribed for without subscription rights shall be made in cash pursuant to instructions on a contract note, however not later than three bank days from the issue of such contract note. The Board of Directors shall have the right to extend the subscription period and the date for payment. The new class B shares shall be issued at the subscription price of SEK 1.50 per share. The new shares shall entitle to dividends for the first time on the record day for dividends which occurs immediately following the date when the class B shares were registered in the share register maintained by Euroclear Sweden AB. The resolution on the Rights Issue of new shares is subject to the Meeting’s subsequent approval as well as the adoption of new Articles of Association of the Company pursuant to item 7 of the proposed agenda. The CEO, or anyone appointed by the CEO, shall be authorised to make such minor adjustments to the resolution as may be required in connection with the registration of the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB or due to other formal requirements. The Board of Directors proposes that the Meeting approves of the Board of Directors’ proposal. Proposal under item 9; Resolution on approval of a directed new issue of shares Subject to the Meeting’s subsequent approval, the Board of Directors in Episurf resolved, on 7 February 2020, on a new directed issue of class B shares (the ”Directed Issue”), with deviation of the preferential rights of the shareholders, on the following main terms and conditions. The Company’s share capital shall be increased with no more than SEK 18,015,235.96 by a new issue of no more than 60,000,000 class B shares. The new shares of series B are to be subscribed for on a separate subscription list at the latest on 2 April 2020. The shares are to be paid for at the latest on 2 April 2020. The Board of Directors shall be entitled to prolong the subscription and payment period. The new shares of class B shall be subscribed at the subscription price of SEK 1.50 per share. The subscription price has been determined through a book building procedure and is assessed by the Board of Directors to correspond to the market value of the shares. The right to subscribe for the new shares of series B shall, with deviation of the preferential rights of the shareholders, be granted to certain institutional investors who previously have announced their interest in subscription. The reason for deviating from the shareholders’ preferential rights is to provide additional capital to the Company in order to finance its continued expansion as well as to provide long-term institutional shareholders and thereby promote Episurf’s potential to develop the Company with the purpose of creating added value for all shareholders. Shares issued in connection with the Directed Issue are not eligible to participate in the Rights Issue. The resolution on the Directed Issue of new shares is subject to the Meeting’s subsequent approval as well as the adoption of new Articles of Association of the Company pursuant to item 7 of the proposed agenda. The CEO, or anyone appointed by the CEO, shall be authorised to make such minor adjustments to the resolution as may be required in connection with the registration of the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB or due to other formal requirements. The Board of Directors proposes that the Meeting approves of the Board of Directors’ proposal. Other As per the date of this notice, the Company has 90,930,755 outstanding shares, of which 971,024 are class A shares with three votes per share and 89,959,731 are class B shares with one vote per share. Accordingly, the total number of votes amounts to 92,872,803. The Company holds no treasury shares. A copy of the Company’s Articles of Association, proxy forms and complete proposals, the statement of the Board of Directors as well as the auditor’s statement pursuant to Chapter 13 Section 6 of the Swedish Companies Act, together with other documents in accordance with the requirements of the Swedish Companies Act, will be available at the Company’s offices (as stated above) and on the Company’s website www.episurf.com. These documents will also be sent by post to shareholders who so request and state their address. The shareholders are reminded of their right to request information from the Board of Directors and the CEO at the Meeting in accordance with Chapter 7, Section 32 of the Swedish Companies Act. For information on how the Company processes your personal data, please see the integrity policy which is available on Euroclear Sweden AB’s website: www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf Welcome! Stockholm in February 2020 The Board of Directors
Extra general meeting 2019
Episurf Medical’s Extra General Meeting was held on Tuesday 7 May, 2019 at 10:00 CEST at Karlavägen 60, 114 49 Stockholm.     Documents:
AGM 2019
Episurf Medical’s Annual General Meeting was held on Monday, April 8, 2019 at 10:00 at Karlavägen 60, 114 49 Stockholm   Documents:
Extra general meeting 2018
Episurf Medical’s Extra General Meeting was held on Friday 7 December, 2018 at 14.00 CET at Karlavägen 60, 114 49 Stockholm.
AGM 2018
Episurf Medical’s Annual General Meeting was held on Monday, April 9, 2018 at 10:00 A.M at Karlavägen 60, 114 49 Stockholm.
AGM 2017
Episurf Medical’s Annual General Meeting was held on Monday, May 22, 2017 at 6:00 P.M at Odenplan 7A, Odengatan 65 in Stockholm, Sweden.
Extra General Meeting 2017
Extraordinary General Meeting was held on Monday 20 February 2017 at 15.00 p.m. (CET) at the premises of the Company, Karlavägen 60, 115 42 in Stockholm.
Extra General Meeting 2016
Extraordinary General Meeting was held on Thursday 18 August 2016 at 10.30 p.m. (CET) at “T-House”, Engelbrektsplan 1, 114 34 in Stockholm Sweden.
General Meetings 2015
Extra General Meeting 21th of August 2015 An extra general meeting in Episurf AB (publ) was held on Friday the 21th of August 2015, 10:00 at T-House, Engelbrektsplan 1, 114 34 in Stockholm. Annual General Meeting 2015 The AGM for financial year 2014 was on May 6, 2015 at the Courtyard Marriott, Kungsholmen, Rålambshovsleden 50, Stockholm.
AGM 2016
The Annual General Meeting was held on Tuesday 24 May 2016 at 18.00 (CET) at “7A Odenplan”, Odengatan 65, SE-113 22 Stockholm.
Previous Meetings
Annual General Meeting June 2014 The Annual General Meeting in June 2014 Episurf Medical AB (publ) was held on Tuesday, June 3, 2014 at 18:00 at Hotel Birger Jarl, conference room Congressen, Birger Jarlsgatan 61 A in Stockholm. Extraordinary general meeting February 2014 At the Special General Meeting on February 12, 2014 it was decided in accordance with the proposal of the nomination committee to appoint Robert Charpentier as a new director. The Board thus consists of five regular members without deputies. Annual general meeting May 2013 The Annual General Meeting for the financial year 2012 was held on 2 May 2013. Special general meeting April 2013 Episurf Medical AB held on Wednesday, April 3, 2013 a Special General Meeting in Stockholm at which the following resolutions were passed: The SGM decided to initiate a private placement in accordance with the Board’s proposal to increase the share capital in the amount of 144,928 shares of series B deviating from existing shareholders’ preferential rights. The right to subscribe for the new shares will lie with Rhenman & Partners Fund – Rhenman Healthcare Equity L/S. Annual general meeting June 2012 Episurf Medical AB held on Monday, 4 June, 2012 its Annual General Meeting in Stockholm. Annual general meeting June 2011 Episurf Medical AB held on Thursday, June 30, 2011 its Annual General Meeting in Stockholm. Special general meeting May 2011 Episurf Medical AB held on Friday, May 13, 2011 a Special General Meeting in Stockholm. The meeting resolved to authorize the Board, through the utilization of existing authority from the General Meeting August 30, 2010, to increase share capital by issuing new shares with preferential rights for existing shareholders.